Embody vs Oak Longevity: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Oak Longevity beats Embody overall, scoring 7.5/10 vs 7.3/10. Oak Longevity is more affordable at $130/mo vs $299/mo. Choose Embody for people who want the oral tirzepatide gum, or who'll pick the. Choose Oak Longevity for budget-conscious users who want one of the cheapest compound.
A side-by-side comparison of Embody and Oak Longevity covering pricing, scores, medication types, insurance, and more to help you decide.
Embody
#38 of 49Online weight-loss program that ships compounded GLP-1 medication to your door. Run by Modern Metabolic Medicine, Inc. and prescribed through CareGLP Affiliated P.C.s, their network of licensed doctors. Two pricing plans run side by side: a promo plan starting at $99/mo for semaglutide (or $149/mo for tirzepatide) that jumps after month 1, and 'Embody Flat' at $299/mo that doesn't go up. Their standout: oral tirzepatide gum, for people who don't want to inject.
Visit EmbodyOak Longevity
#26 of 49Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing — patients pay each month manually rather than auto-renew.
Visit Oak Longevity| Feature | Embody | Oak Longevity |
|---|---|---|
| Our Score | 7.3/10 | 7.5/10 |
| Starting Price | $299/mo | $130/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | People who want the oral tirzepatide gum, or who'll pick the $299/mo flat plan with eyes open instead of the teaser plan | Budget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin) |
| Ranking | #38 | #26 |
Pros & Cons Compared
Embody
Pros
- +Cheap first month — $99 for semaglutide or $149 for tirzepatide. Among the lowest entry prices in the category.
- +Oral tirzepatide gum is rare. Real option for needle-phobic users. (How well it absorbs vs the FDA-approved injection isn't published.)
- +'Embody Flat' plan is $299/mo flat with no surprise increases — predictable if you pick it from the start.
- +100% money-back guarantee in writing: if you follow the program and don't see results in 6 months, they say they'll make it right.
- +Replies to every negative Trustpilot review, usually within 24 hours.
Cons
- −Recurring complaint: people sign up at $149 month 1, get billed $299–$399 in month 2. Embody admits in replies that two plans exist (promo + flat) and the switchover isn't always clear at signup.
- −Trustpilot rating is 3.3 / 5 across 46 reviews — heavily split: 41% love it, 24% give 1 star. Price is the top complaint theme.
- −Embody won't tell you which pharmacy makes the medication — just 'multiple USA certified pharmacies.' This is the norm in the category — most major brands (Embody, Henry, Hims, Yucca, Eden) don't publicly name their pharmacy partners.
- −No HIPAA disclosure on their site (HIPAA is the federal law protecting your medical info — most telehealth providers publish a statement confirming they follow it).
- −Compounded medications only — no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
- −If you stop treatment and come back, Embody's doctors will likely restart you at the lowest dose (2.5mg). It's their safety policy — some users find it overly cautious.
Oak Longevity
Pros
- +$130/mo for compounded semaglutide is among the cheapest entries on the market — Sprout Health ($99) is lower, but Oak undercuts most mid-tier platforms
- +Compounded tirzepatide at $199/mo is competitively priced for a GLP-1+GIP dual agonist
- +No-subscription model — patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
- +Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
- +Money-back guarantee if not approved by physician — useful safety net for borderline-eligibility patients
- +Free shipping and free health coaching included in every program
Cons
- −Brand-name pricing ($1,200-$1,500/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo, LillyDirect Zepbound $299/mo. Never buy brand-name through Oak
- −No published lab panels, no specialty (obesity medicine) physicians disclosed — clinical depth is shallow
- −'Up to 50% cheaper than competitors' marketing claim is unverified and inconsistent — depends on which competitor and which medication tier
- −'Longevity' framing pushes users toward add-on products (NAD+, Sermorelin, Tesamorelin) that have limited clinical evidence for weight loss specifically
- −Newer brand without disclosed company history, founding date, or executive team on landing pages
- −Three-month plans are billed upfront — pricing transparency is good, but commit-up-front is a friction point for users testing the platform
Our Verdict
Oak Longevity edges out Embody with a score of 7.5/10 vs 7.3/10. If budget is your priority, Oak Longevity starts at $130/mo compared to Embody's $299/mo. Oak Longevity offers both brand-name and compounded medications, giving you more flexibility. Choose Embody if you want: people who want the oral tirzepatide gum, or who'll pick the $299/mo flat plan with eyes open instead of the teaser plan. Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin).
Read Full Reviews
Related comparisons
Other matchups readers comparing Embody or Oak Longevity tend to look at next.
- Embody vs MyStart Health$299/mo
- Embody vs Direct Meds GLP-1$297/mo
- Embody vs Maximus$300/mo
- Oak Longevity vs Found$264/mo
- Oak Longevity vs GobyMeds$169/mo
- Oak Longevity vs Zealthy$286/mo